Tag: VEITH 2025
Interim results of covered stent-graft hint at ‘new avenue’ in dialysis...
The interim results of a first-in-human trial of a sirolimus-eluting covered stent graft—Solaris DE (Solaris Endovascular)—for the treatment of dialysis access dysfunction demonstrate the...
PERT, AI and the rise of thrombectomy devices: ‘PERT leads to...
The increasing sophistication of the device space for the treatment of pulmonary embolism (PE) aligned with advances in the deployment of pulmonary embolism response...
Vascular Specialist–November/December 2025
In this issue:
CREST-2: Landmark trial finds benefit from carotid stenting
One-year results from IVC stent clinical trial show positive safety and efficacy data
...
CREST-2: Landmark trial finds benefit from carotid stenting
The National Institutes of Health (NIH)-funded CREST-2 study has found that, for people with high-grade asymptomatic carotid artery stenosis who have not experienced recent...
‘Historical’ CREST-2 data show reduced stroke risk with carotid stenting versus...
The international CREST-2 study has found that, for people with severe carotid artery narrowing who have not experienced recent stroke symptoms, a minimally invasive...
Atherectomy in PAD: Meta-analysis of ‘extensive’ published literature supports use in...
A systematic review and meta-analysis of more than 300 original investigations on atherectomy in peripheral arterial disease (PAD) highlights “overall favorable” clinical outcomes. This...